ABC Classification Is Less Useful for Older Koreans Born before 1960
1
조회
0
다운로드
7
인용
0
참고문헌
키워드
초록
Background/Aims: In the ABC classification system, group A consists of seronegative subjects without gastric corpus atrophy. This study aimed to determine the prevalence and characteristics of pseudo group A subjects. Methods: Group A subjects were identified among consecutive Korean adults who underwent a serum anti-Helicobacter pylori immunoglobulin G (IgG) test and pepsinogen (PG) assay on the day of endoscopy. Past infection was defined as the presence of either eradication history or endoscopic findings suggesting past infection (i.e., gastric xanthoma, metaplastic gastritis, or advanced atrophy >closed-type 1). Results: Among 2,620 group A subjects, 448 (17.1%) had eradication history, and 133 (5.1%) showed endoscopic findings suggesting past infection. Older age (odds ratio [OR], 1.148; 95% confidence interval [CI], 1.067 to 1.236) and earlier year of birth (OR, 1.086; 95% CI, 1.009 to 1.168) were independent risk factors for classification into pseudo group A, with cutoff points at 50.5 years and birth year of 1959.5, respectively. Positive H. pylori test findings were found in 22 subjects (3.1%) among the 715 subjects who underwent the urea breath test or Giemsa staining on the same day. Current infection was positively correlated with PG I and PG II levels (p<0.001) but not with age, anti-H. pylori IgG titer, or classification into pseudo group A. Conclusions: Among the group A subjects, 22.2% had past infection. The risk was higher in subjects older than 50 years, especially those born before 1960. Furthermore, current infection was found in 3.1% of the subjects and was correlated with increased gastric secretory ability.
Abstract
Background/Aims: In the ABC classification system, group A consists of seronegative subjects without gastric corpus atrophy. This study aimed to determine the prevalence and characteristics of pseudo group A subjects. Methods: Group A subjects were identified among consecutive Korean adults who underwent a serum anti-Helicobacter pylori immunoglobulin G (IgG) test and pepsinogen (PG) assay on the day of endoscopy. Past infection was defined as the presence of either eradication history or endoscopic findings suggesting past infection (i.e., gastric xanthoma, metaplastic gastritis, or advanced atrophy >closed-type 1). Results: Among 2,620 group A subjects, 448 (17.1%) had eradication history, and 133 (5.1%) showed endoscopic findings suggesting past infection. Older age (odds ratio [OR], 1.148; 95% confidence interval [CI], 1.067 to 1.236) and earlier year of birth (OR, 1.086; 95% CI, 1.009 to 1.168) were independent risk factors for classification into pseudo group A, with cutoff points at 50.5 years and birth year of 1959.5, respectively. Positive H. pylori test findings were found in 22 subjects (3.1%) among the 715 subjects who underwent the urea breath test or Giemsa staining on the same day. Current infection was positively correlated with PG I and PG II levels (p<0.001) but not with age, anti-H. pylori IgG titer, or classification into pseudo group A. Conclusions: Among the group A subjects, 22.2% had past infection. The risk was higher in subjects older than 50 years, especially those born before 1960. Furthermore, current infection was found in 3.1% of the subjects and was correlated with increased gastric secretory ability.
참고문헌 (31)
- Plummer M, "Global burden of gastric cancer attributable to Helicobacter pylori", Int J Cancer, 136, pp.487~490 (2015)
- Hooi JKY, "Global prevalence of helicobacter pylori infection : systematic review and meta-analysis", Gastroenterology, 153, pp.420~429 (2017)
- Peleteiro B, "Prevalence of Helicobacter pylori infection worldwide : a systematic review of studies with national coverage", Dig Dis Sci, 59, pp.1698~1709 (2014)
- Carneiro F, "World cancer report", pp.383~391 (2014), International Agency for Research on Cancer
- Shin A, "Population attributable fraction of infection-related cancers in Korea", Ann Oncol, 22, pp.1435~1442 (2011)
- Lee JH, "Seroprevalence of Helicobacter pylori in Korea : a multicenter, nationwide study conducted in 2015 and 2016", Helicobacter, 23, pp.e12463~ (2018)
- Miki K, "Long-term results of gastric cancer screening using the serum pepsinogen test method among an asymptomatic middle-aged Japanese population", Dig Endosc, 21, pp.78~81 (2009)
- Yamaguchi Y, "Gastric cancer screening by combined assay for serum anti-Helicobacter pylori IgG antibody and serum pepsinogen levels : the ABC Method", Digestion, 93, pp.13~18 (2016)
- Miki K, "Gastric cancer screening by combined assay for serum anti-Helicobacter pylori IgG antibody and serum pepsinogen levels : "ABC method"", Proc Jpn Acad Ser B Phys Biol Sci, 87, pp.405~414 (2011)
- Choi HS, "Combining the serum pepsinogen level and Helicobacter pylori antibody test for predicting the histology of gastric neoplasm", J Dig Dis, 15, pp.293~298 (2014)
- Watabe H, "Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status : a prospective endoscopic cohort study", Gut, 54, pp.764~768 (2005)
- Kiso M, "Characteristics of gastric cancer in negative test of serum anti-Helicobacter pylori antibody and pepsinogen test : a multicenter study", Gastric Cancer, 20, pp.764~771 (2017)
- Kishikawa H, "Cutoff pepsinogen level for predicting unintendedly eradicated cases of Helicobacter pylori infection in subjects with seemingly normal pepsinogen levels", Digestion, 95, pp.229~236 (2017)
- Chinda D, "Serum pepsinogen levels indicate the requirement of upper gastrointestinal endoscopy among group A subjects of ABC classification : a multicenter study", J Gastroenterol, 53, pp.924~931 (2018)
- Boda T, "Advanced method for evaluation of gastric cancer risk by serum markers : determination of true low-risk subjects for gastric neoplasm", Helicobacter, 19, pp.1~8 (2014)
- Yuji Maehata, "Characteristics of Primary and Metachronous Gastric Cancers Discovered after Helicobacter pylori Eradication: A Multicenter Propensity Score-Matched Study", Gut and Liver, 11(5), pp.628~634 (2017), 거트앤리버 소화기연관학회협의회
- 이상표, "Link between Serum Pepsinogen Concentrations and Upper Gastrointestinal Endoscopic Findings", Journal of Korean Medical Science, 32(5), pp.796~802 (2017), 대한의학회
- Kimura K, "An endoscopic recognition of the atrophic border and its significance in chronic gastritis", Endoscopy, 1, pp.87~97 (1969)
- Sugimoto M, "Efficacy of the Kyoto classification of gastritis in identifying patients at high risk for gastric cancer", Intern Med, 56, pp.579~586 (2017)
- Lee SY, "Validation of western Helicobacter pylori IgG antibody assays in Korean adults", J Med Microbiol, 64, pp.513~518 (2015)
- Kim JH, "The histologic detection of Helicobacter pylori in seropositive subjects is affected by pathology and secretory ability of the stomach", Helicobacter, 23, pp.e12480~ (2018)
- 이선영, "Endoscopic gastritis, serum pepsinogen assay, and Helicobacter pylori infection", The Korean Journal of Internal Medicine, 31(5), pp.835~844 (2016), 대한내과학회[DOI]
- Koizumi W, "Effect of anti-Helicobacter pylori IgG antibody titer following eradication of Helicobacter pylori infection", Hepatogastroenterology, 50, pp.293~296 (2003)
- Ohkusa T, "Improvement in serum pepsinogens and gastrin in long-term monitoring after eradication of Helicobacter pylori: comparison with H. pylori-negative patients", Aliment Pharmacol Ther, 20, pp.25~32 (2004)
- Miura K, "Actual status of involvement of Helicobacter pylori infection that developed gastric cancer from group A of ABC(D)Stratification-study of early gastric cancer cases that underwent endoscopic submucosal dissection", Digestion, 94, pp.17~23 (2016)
- Kotachi T, "Serological evaluation of gastric cancer risk based on pepsinogen and Helicobacter pylori antibody : relationship to endoscopic findings", Digestion, 95, pp.314~318 (2017)
- Shimoyama T, "ABC screening for gastric cancer is not applicable in a Japanese population with high prevalence of atrophic gastritis", Gastric Cancer, 15, pp.331~334 (2012)
- Kang JM, "Predictive factors for improvement of atrophic gastritis and intestinal metaplasia after Helicobacter pylori eradication : a three-year follow-up study in Korea", Helicobacter, 17, pp.86~95 (2012)
- Nam SY, "Longterm follow-up of pepsinogen I", II ratio after eradication of Helicobacter pylori in patients who underwent endoscopic mucosal resection for gastric cancer, 2017, pp.49, 500~506
- Daugule I, "Long-term dynamics of gastric biomarkers after eradication of Helicobacter pylori infection", Eur J Gastroenterol Hepatol, 27, pp.501~505 (2015)
- Vannella L, "Reversal of atrophic body gastritis after H. pylori eradication at long-term follow-up", Dig Liver Dis, 43, pp.295~299 (2011)